Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.50 |
| ▸ | CA2 | P00918 | 2/20 | 0.50 |
| ▸ | POLB | P06746 | 2/20 | 0.50 |
| ▸ | TYR | P14679 | 1/20 | 0.50 |
| ▸ | HSPA5 | P11021 | 1/20 | 0.43 |
| ▸ | CYP2C9 | P11712 | 3/20 | 0.42 |
| ▸ | CYP2C19 | P33261 | 3/20 | 0.42 |
| ▸ | HIF1A | Q16665 | 3/20 | 0.42 |
| ▸ | LMNA | P02545 | 4/20 | 0.39 |
| ▸ | TSHR | P16473 | 3/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | GMNN | O75496 | 1/20 | 0.39 |
| ▸ | GABBR2 | O75899 | 1/20 | 0.39 |
| ▸ | TP53 | P04637 | 1/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.39 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.39 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL727872 | 0.89 | NR5A2 (0.44) | ALDH1A1SMN1; SMN2CA2POLBTYR | |
| Butylated Hydroxytoluene SCHEMBL2952153 | 0.87 | CA2 (0.43) | ALDH1A1SMN1; SMN2CA2POLBTYR | |
| SCHEMBL2793568 | 0.84 | NR5A2 (0.47) | ALDH1A1SMN1; SMN2CA2POLBTYR | |
| SCHEMBL2952154 | 0.83 | CYP3A4 (0.34) | ALDH1A1SMN1; SMN2CA2POLBTYR | |
| SCHEMBL11262061 | 0.80 | ALDH1A1 (0.55) | ALDH1A1SMN1; SMN2CA2POLBTYR | |
| Phosphoric Acid SCHEMBL2954109 | 0.78 | NR5A2 (0.48) | ALDH1A1SMN1; SMN2CA2POLBTYR | |
| Butylated Hydroxytoluene SCHEMBL27452988 | 0.78 | SMN1; SMN2 (0.75) | ALDH1A1SMN1; SMN2CA2POLBTYR | |
| Butylated Hydroxytoluene SCHEMBL28288111 | 0.78 | CA2 (0.75) | ALDH1A1SMN1; SMN2CA2POLBTYR | |
| SCHEMBL7598159 | 0.77 | CYP2C9 (0.40) | ALDH1A1SMN1; SMN2CA2POLBTYR | |
| SCHEMBL2951541 | 0.77 | NR5A2 (0.42) | ALDH1A1SMN1; SMN2CA2POLBTYR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 52 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4251690-A1 | COMPOSITIONS AND METHODS FOR PROTECTING ORGANIC POLYMERIC MATERIALS FROM THE DELETERIOUS EFFECTS EXPOSURE TO UV-C LIGHT | Cytec Industries Inc. (US) | 2023-10-04 | — | — | EP | claimed |
| CN-116745353-A | Compositions and methods for protecting organic polymeric materials from the deleterious effects of UV-C light exposure | 塞特工业公司 | 2023-09-12 | — | — | CN | claimed |
| WO-2023129464-A1 | POLYMER COMPOSITIONS HAVING DENSIFICATION ACCELERATORS AND ROTATIONAL MOLDING PROCESSES FOR MAKING HOLLOW ARTICLES THEREFROM | CYTEC INDUSTRIES INC. (US) | 2023-07-06 | — | — | WO | claimed |
| EP-2864310-B1 | STABILIZER COMPOSITIONS CONTAINING SUBSTITUTED CHROMAN COMPOUNDS AND METHODS OF USE | CYTEC TECH CORP (US) | 2022-10-26 | — | — | EP | claimed |
| US-20220212375-A1 | POLYMERIC HOLLOW ARTICLES CONTAINING CHROMAN-BASED COMPOUNDS AND MADE BY ROTATIONAL MOLDING | CYTEC TECHNOLOGY CORP. | 2022-07-07 | — | — | US | claimed |
| US-20220169829-A1 | COMPOSITIONS AND METHODS FOR PROTECTING ORGANIC POLYMERIC MATERIALS FROM THE DELETERIOUS EFFECTS OF EXPOSURE TO UV-C LIGHT | CYTEC INDUSTRIES INC. (US) | 2022-06-02 | — | — | US | claimed |
| WO-2022115578-A1 | COMPOSITIONS AND METHODS FOR PROTECTING ORGANIC POLYMERIC MATERIALS FROM THE DELETERIOUS EFFECTS EXPOSURE TO UV-C LIGHT | CYTEC INDUSTRIES INC. (US) | 2022-06-02 | — | — | WO | claimed |
| US-20220153959-A1 | POLYOLEFIN COMPOSITIONS CONTAINING SUBSTITUTED CHROMAN COMPOUNDS AND MOLDED ARTICLES PRODUCED THEREFROM | CYTEC TECHNOLOGY CORP. | 2022-05-19 | — | — | US | claimed |
| CN-110669255-B | Stabilizer compositions containing substituted chroman compounds and methods of use thereof | 塞特克技术公司 | 2021-09-14 | — | — | CN | claimed |
| US-10975278-B2 | Granular stabilizer compositions for use in polymer resins and methods of making same | CYTEC INDUSTRIES INC. (US) | 2021-04-13 | — | — | US | claimed |
| CN-112055728-A | Particulate stabilizer composition for polymer resins and process for producing the same | 塞特工业公司 | 2020-12-08 | — | — | CN | claimed |
| EP-2652014-B1 | PROCESSING ADDITIVES AND USES OF SAME IN ROTATIONAL MOLDING | CYTEC TECH CORP (US) | 2020-07-01 | — | — | EP | claimed |
| CN-110669255-A | Stabilizer compositions containing substituted chroman compounds and methods of use thereof | 塞特克技术公司 | 2020-01-10 | — | — | CN | claimed |
| US-20190264084-A1 | GRANULAR STABILIZER COMPOSITIONS FOR USE IN POLYMER RESINS AND METHODS OF MAKING SAME | CYTEC INDUSTRIES INC. (US) | 2019-08-29 | — | — | US | claimed |
| US-20130145962-A1 | Stabilizer Compositions Containing Substituted Chroman Compounds and Methods of Use | CYTEC TECHNOLOGY CORP. (US) | 2013-06-13 | — | — | US | claimed |
| US-20120146257-A1 | PROCESSING ADDITIVES AND USES OF SAME IN ROTATIONAL MOLDING | CYTEC TECHNOLOGY CORP. (US) | 2012-06-14 | — | — | US | claimed |
| US-20100256266-A1 | STABILIZER COMPOSITIONS | CYTEC TECHNOLOGY CORP. (US) | 2010-10-07 | — | — | US | claimed |
| US-7759417-B2 | Stabilizer compositions | CYTEC TECHNOLOGY CORP. (US) | 2010-07-20 | — | — | US | claimed |
| US-20090149581-A1 | STABILIZER COMPOSITIONS | CYTEC TECHNOLOGY CORP. (US) | 2009-06-11 | — | — | US | claimed |
| WO-2007136565-A1 | STABILIZER COMPOSITIONS | CYTEC TECHNOLOGY CORP. (US) | 2007-11-29 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220212375-A1 | POLYMERIC HOLLOW ARTICLES CONTAINING CHROMAN-BASED COMPOUNDS AND MADE BY ROTATIONAL MOLDING | RPS7, MRPS27, F7 | ALDH1A1 4376/4885SMN1; SMN2 3257/4885CA2 734/4885 |
| US-20220153959-A1 | POLYOLEFIN COMPOSITIONS CONTAINING SUBSTITUTED CHROMAN COMPOUNDS AND MOLDED ARTICLES PRODUCED THEREFROM | NOTUM, PMM2, WASF2 | ALDH1A1 4580/4885SMN1; SMN2 1802/4885CA2 112/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.